Skip to site services
Skip to top navigation
Skip to left navigation
Skip to site tools
Skip to main content
Skip to footer
Alert service | Downloads | Glossary | Print this page Print this page | Site map
Search

2006

Register for our Alert Service if you would like to be alerted when a news release is added to the site.

Date Title
21 Dec 2006 Vectura announces US collaboration agreement for its combination asthma therapy - VR315
13 Dec 2006 Vectura EGM approves the recommended offer for Innovata plc
29 Nov 2006 Vectura Announces that QVA149 Clinical Development starts in 2007 and Updates the Status of NVA237
17 Nov 2006 Interim Results for six months ended 30 September 2006
17 Nov 2006 Planned acquisition of Innovata plc by Vectura
16 Nov 2006 Vectura spin-out PharmaKodex Ltd raises £7.1m
28 Sep 2006 Annual General Meeting
08 Aug 2006 Vectura announces successful outcome of phase II study on inhaled parkinson’s disease product – VR040
24 Jul 2006 Vectura EGM approves £45 million new share Placing
28 Jun 2006 Vectura announces successful outcome of Phase IIb study for VR004
28 Jun 2006 Vectura and Sosei announce successful outcome of Phase IIb study for NVA237
28 Jun 2006 Vectura announces intention to complete £45m placing
25 May 2006 Preliminary Results for the Year Ended 31 March 2006
15 May 2006 Vectura and Unilever Ventures announce the spin out of Pharmakodex, a new speciality pharmaceutical company
19 Apr 2006 Vectura announces agreement with Boehringer Ingelheim on a new inhaler
04 Apr 2006 Vectura Announces First Product Deal in GyroHaler®
18 Jan 2006 Vectura Announces EMEA Orphan Drug Designation for its Inhaled Product for Parkinson’s Disease

Innovata press releases
Date Title
20 Dec 2006 Results of Court Meeting and Innovata EGM
17 Nov 2006 Vectura Group plc ("Vectura") and Innovata plc ("Innovata") - Recommended offer for Innovata by Vectura
17 Nov 2006 Vectura Group plc - Interim Results for six months ended 30 September 2006
17 Nov 2006 Preliminary results for the year ended 30 September 2006
25 Sep 2006 Settlement of legal proceedings with Pall Corporation
01 Aug 2006 FDA approves ADEPT® Adhesion Reduction Solution (4% Icodextrin Solution)
01 Jun 2006 Innovata plc announces interim results for the period ended 31 March 2006
01 Jun 2006 FDA Issues Approvable Letter for ADEPT® Adhesion Reduction Solution
28 Mar 2006 FDA panel recommends approval of ADEPT® Adhesion Reduction Solution
15 Mar 2006 AGM statement
17 Feb 2006 Legal proceedings against Pall Corporation
06 Feb 2006 Annual Report for year ended 30 September 2005
11 Jan 2006 Innovata plc terminates merger discussions
11 Jan 2006 Preliminary results for the year ended 30 September 2005
03 Jan 2006 Innovata plc announces Baxter International Inc. as global licensee for Adept® Adhesion Reduction Solution


Delivered by Investis logo and link to website (opens in a new window)